NASDAQ : CLPT

ClearPoint Neuro, Inc. — Financial statements

Healthcare · Medical Devices · United States

Last price 10.69 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 342.63M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

ClearPoint Neuro, Inc. (CLPT) reported revenue of 45.49M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue45.49M36.97M31.39M23.95M20.55M16.30M
Cost of Revenue17.56M14.28M12.27M10.34M7.02M5.18M
Gross Profit27.93M22.69M19.12M13.61M13.53M11.12M
Selling, General & Admin41.82M31.16M26.46M24.35M18.97M15.22M
Research & Development16.41M13.90M12.39M11.71M10.89M9.28M
Operating Expenses58.23M45.06M38.86M36.06M29.86M24.50M
Operating Income-30.30M-22.36M-19.73M-22.45M-16.33M-13.37M
Interest Expense-5.33M-2.39M-518.00K-81.00K-973.00K
Interest & Investment Income1.31M1.21M1.39M386.00K
Other Non Operating Income (Expenses)-54.00K-146.00K-40.00K-29.00K-22.00K-63.00K
EBT Excluding Unusual Items-34.37M-23.68M-18.90M-22.09M-16.43M-14.41M
Merger & Restructuring Charges-1.80M-1.80M
Pretax Income-36.16M-25.48M-18.90M-22.09M-16.43M-14.41M
Income Tax Expense-30.00K55.00K12.00K
Net Income-36.13M-25.54M-18.91M-22.09M-16.43M-14.41M
Net Income to Common-36.13M-25.54M-18.91M-22.09M-16.43M-14.41M
Shares Outstanding (Basic)29.89M28.32M27.03M24.61M24.18M20.73M
Shares Outstanding (Diluted)29.89M28.32M27.03M24.61M24.18M20.73M
EPS (Basic)-1.21-0.90-0.70-0.90-0.68-0.69
EPS (Diluted)-1.21-0.90-0.70-0.90-0.68-0.69
Free Cash Flow-33.22M-24.45M-9.22M-14.44M-16.42M-12.87M
Free Cash Flow Per Share-1.11-0.86-0.34-0.59-0.68-0.62
Gross Margin61.39%61.38%60.92%56.83%65.84%68.24%
Operating Margin-66.60%-60.49%-62.87%-93.70%-79.47%-82.05%
Profit Margin-79.43%-69.08%-60.26%-92.21%-79.97%-88.41%
Free Cash Flow Margin-73.02%-66.12%-29.39%-60.27%-79.90%-78.93%
EBITDA-29.02M-21.48M-18.75M-21.82M-16.09M-13.21M
EBITDA Margin-63.80%-58.10%-59.75%-91.09%-78.28%-81.08%
D&A For EBITDA1.27M883.00K980.00K626.00K244.00K159.00K
EBIT-30.30M-22.36M-19.73M-22.45M-16.33M-13.37M
EBIT Margin-66.60%-60.49%-62.87%-93.70%-79.47%-82.05%
Revenue as Reported45.49M36.97M31.39M23.95M20.55M16.30M

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents46.18M45.92M20.10M23.14M27.61M54.11M
Short-Term Investments9.87M
Cash & Short-Term Investments46.18M45.92M20.10M23.14M37.49M54.11M
Receivables9.08M7.26M5.36M3.94M2.71M2.34M
Inventory9.77M8.36M6.86M7.91M9.30M4.94M
Prepaid Expenses1.68M2.06M1.04M1.18M1.35M508.00K
Other Current Assets327.00K
Total Current Assets66.71M63.60M33.36M36.17M51.18M61.89M
Property, Plant & Equipment24.32M11.05M5.09M4.95M2.70M2.78M
Goodwill7.47M7.47M
Other Intangible Assets12.41M13.92M1.04M1.03M265.00K
Other Long-Term Assets1.81M1.70M735.00K495.00K581.00K644.00K
Total Assets112.73M97.75M39.19M42.66M55.49M65.58M
Accounts Payable1.06M1.26M1.34M393.00K272.00K427.00K
Accrued Expenses7.06M7.15M6.33M4.00M4.89M3.14M
Current Portion of Leases198.00K694.00K557.00K424.00K561.00K507.00K
Current Unearned Revenue1.55M1.67M2.12M2.61M1.07M678.00K
Total Current Liabilities9.87M10.77M10.35M7.43M6.79M4.75M
Long-Term Debt50.84M49.08M9.95M9.89M9.84M
Long-Term Leases22.66M8.46M3.01M3.57M1.53M1.94M
Long-Term Unearned Revenue428.00K581.00K436.00K541.00K390.00K264.00K
Long-Term Deferred Tax Liabilities305.00K354.00K
Other Long-Term Liabilities1.36M489.00K
Total Liabilities85.46M69.73M13.80M21.49M18.60M16.79M
Common Stock320.00K294.00K276.00K247.00K246.00K237.00K
Additional Paid-In Capital269.64M239.00M216.48M193.38M187.01M182.48M
Retained Earnings-245.26M-216.91M-191.37M-172.46M-150.37M-133.93M
Comprehensive Income & Other2.57M5.64M
Shareholders' Equity27.27M28.02M25.39M21.17M36.89M48.79M
Total Liabilities & Equity112.73M97.75M39.19M42.66M55.49M65.58M
Total Debt73.70M58.23M3.57M13.94M11.99M12.28M
Net Cash (Debt)-27.52M-12.31M16.54M9.20M25.50M41.83M
Net Cash Per Share-0.92-0.430.610.371.052.02
Filing Date Shares Outstanding32.05M29.66M27.63M26.98M24.61M23.69M
Total Common Shares Outstanding32.05M29.37M27.62M24.65M24.58M23.67M
Working Capital56.84M52.84M23.01M28.74M44.39M57.14M
Book Value Per Share0.850.950.920.861.502.06
Tangible Book Value7.38M6.63M25.39M20.13M35.86M48.52M
Tangible Book Value Per Share0.230.230.920.821.462.05
Machinery3.85M2.86M1.85M2.37M2.23M
Leasehold Improvements485.00K485.00K485.00K201.00K201.00K

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-36.13M-25.54M-18.91M-22.09M-16.43M-14.41M
Depreciation & Amortization3.97M2.14M1.90M1.46M777.00K692.00K
Other Amortization1.17M182.00K51.00K57.00K55.00K100.00K
Loss (Gain) From Sale of Investments-126.00K-284.00K
Stock-Based Compensation8.35M8.18M6.91M6.08M4.13M2.08M
Provision & Write-off of Bad Debts-853.00K21.00K-296.00K1.26M-117.00K202.00K
Other Operating Activities1.98M908.00K325.00K
Change in Accounts Receivable-1.58M-268.00K-1.21M-1.80M-211.00K-658.00K
Change in Inventory-1.29M-103.00K743.00K1.25M-4.42M-1.71M
Change in Accounts Payable-6.27M-7.52M3.10M-649.00K1.59M1.28M
Change in Unearned Revenue-522.00K-319.00K-597.00K1.70M515.00K165.00K
Change in Other Net Operating Assets-991.00K-1.60M-646.00K-846.00K-1.76M-762.00K
Operating Cash Flow-32.17M-23.93M-8.95M-13.72M-16.17M-12.70M
Capital Expenditures-1.04M-522.00K-275.00K-717.00K-253.00K-168.00K
Cash Acquisitions1.14M1.14M
Sale (Purchase) of Intangibles-334.00K-893.00K
Investment in Securities10.00M-9.59M
Investing Cash Flow92.00K615.00K-275.00K8.95M-10.74M-168.00K
Long-Term Debt Issued48.09M
Total Debt Issued19.43M48.09M
Long-Term Debt Repaid-10.00M
Net Debt Issued (Repaid)19.43M48.09M-10.00M
Issuance of Common Stock23.55M3.95M16.61M506.00K745.00K47.47M
Repurchase of Common Stock-2.19M-1.86M-424.00K-210.00K-336.00K-599.00K
Financing Cash Flow40.79M50.18M6.19M296.00K409.00K46.88M
Net Cash Flow8.71M26.87M-3.04M-4.47M-26.49M34.01M
Free Cash Flow-33.22M-24.45M-9.22M-14.44M-16.42M-12.87M
Free Cash Flow Margin-73.02%-66.12%-29.39%-60.27%-79.90%-78.93%
Free Cash Flow Per Share-1.11-0.86-0.34-0.59-0.68-0.62
Levered Free Cash Flow-15.28M-9.63M-1.51M-6.05M-10.37M-7.24M
Unlevered Free Cash Flow-12.13M-8.23M-1.24M-6.11M-10.38M-6.74M
Cash Interest Paid2.03M908.00K480.00K743.00K523.00K597.00K
Cash Income Tax Paid34.00K69.00K62.00K
Change in Working Capital-10.65M-9.81M1.40M-356.00K-4.29M-1.68M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization318.94M406.96M424.25M167.17M207.98M265.24M
Enterprise Value346.45M404.48M406.37M156.85M179.47M227.76M
Last Close Price10.6713.6815.386.798.4711.22
PS Ratio7.0411.0113.526.9810.1216.27
PB Ratio12.5414.5216.717.905.645.44
P/TBV Ratio43.3761.4216.718.305.805.47
EV/Sales Ratio7.6410.9412.956.558.7313.97
Debt / Equity Ratio2.702.080.140.660.330.25
Net Debt / Equity Ratio1.010.44-0.65-0.43-0.69-0.86
Net Debt / EBITDA Ratio-0.95-0.570.880.421.583.17
Net Debt / FCF Ratio-0.83-0.501.790.641.553.25
Asset Turnover0.530.540.770.490.340.34
Inventory Turnover2.151.881.661.200.991.27
Quick Ratio5.604.942.463.655.9211.88
Current Ratio6.765.913.224.877.5413.02
Return on Equity (ROE)-167.52%-95.64%-81.24%-76.09%-38.37%-56.33%
Return on Assets (ROA)-21.88%-20.41%-30.14%-28.59%-16.86%-17.58%
Return on Capital Employed (ROCE)-29.50%-25.70%-68.40%-63.70%-33.50%-22.00%
Earnings Yield-12.15%-6.28%-4.46%-13.21%-7.90%-5.43%
FCF Yield-10.37%-6.01%-2.17%-8.64%-7.90%-4.85%
Buyback Yield / Dilution-6.75%-4.76%-9.84%-1.75%-16.63%-30.82%